Tedizolid gets a thumbs up


Ad comm vote is 14-0 recommending approval for Cubist Pharmaceuticals' (CBST +1.7%) tedizolid according to market chatter.

From other sites
Comments (2)
  • Rhinoish
    , contributor
    Comments (125) | Send Message
     
    no surprise there.
    31 Mar 2014, 12:35 PM Reply Like
  • bwaredog
    , contributor
    Comments (4) | Send Message
     
    Cvr will be paying sound like
    31 Mar 2014, 09:28 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs